Keith Harris Net Worth

Keith Harris biography

Dr. Keith R. Harris, Ph.D. is Independent Chairman of the Board of the Company. He has served as a member of our board of directors since June 2015 and served as chairman of our board of directors since February 2018. Dr. Harris is a London-based investment banker and financier with a 25-year career as a senior corporate finance and takeover advisor. Since 1999, Dr. Harris has been the chairman of Keith Harris & Associates, a sports consulting firm. Dr. Harris previously served as Chief Executive Officer of HSBC Investment Bank from 1994 to 1999 and Seymour Pierce Holdings Limited, a subsidiary of which, Seymour Pierce Limited, was acquired in a pre-paid administration under U.K. law in 2013. Dr. Harris received a B.A. in business and economics from the University of Bradford and a Ph.D. in Economics from the University of Surrey.

How old is Keith Harris?

Keith Harris is 65, he’s been the Independent Chairman of the Board of MeiraGTx Plc since 2018. There are 3 older and 7 younger executives at MeiraGTx Plc. The oldest executive at MeiraGTx Holdings Plc is Arnold Levine, 78, who is the Independent Director.

What’s Keith Harris’s mailing address?

Keith’s mailing address filed with the SEC is 430 E. 29TH STREET, 10TH FLOOR, , NEW YORK, NY, 10016.

Insider trading at MeiraGTx Plc

Over the last few years, insiders at MeiraGTx Plc have traded over $0 worth of MeiraGTx Plc stock and bought 3,113,212 units worth $48,763,809 . The most active insider traders include Advisors Llcperceptive Life…, Life Sciences Master Fund L…, and Joel S Marcus. On average, MeiraGTx Plc executives and independent directors trade stock every 143 days with the average trade being worth of $15,182,092. The most recent stock trade was executed by Advisors Llcperceptive Life… on 12 August 2019, trading 425,531 units of MGTX stock currently worth $9,999,979.

What does MeiraGTx Plc do?

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

What does MeiraGTx Plc’s logo look like?

MeiraGTx Plc executives and stock owners

MeiraGTx Plc executives and other stock owners filed with the SEC include:

• Alexandria Forbes, President, Chief Executive Officer, Director
• Richard Giroux, Chief Financial Officer, Chief Operating Officer
• Stuart Naylor, Chief Development Officer
• Gregory Moss, Independent Director
• Neil Mendoza, Independent Director
• Joel Marcus, Independent Director
• Arnold Levine, Independent Director
• Martin Indyk, Director
• Ellen Hukkelhoven, Independent Director
• Thomas Shenk, Director
• Nicole Seligman, Director
• Keith Harris, Independent Chairman of the Board
• Advisors Llcperceptive Life…,
• Katherine Breedis, Chief Financial Officer
• Life Sciences Master Fund L…,
• Bruce Gottlieb, General Counsel
• Advisors Llcedelman Joseph …,